477
Views
6
CrossRef citations to date
0
Altmetric
Essure for Hydro Salpinx Treatment

Essure a novel option for the treatment of hydrosalpinx: a case series and literature review

, , , , &
Pages 166-170 | Received 19 Jun 2015, Accepted 30 Sep 2015, Published online: 29 Oct 2015

References

  • Evers JLH. Female subfertility. Lancet 2002;360:151–9
  • Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization–embryo transfer. Fertil Steril 1998;70:492–9
  • Camus E, Poncelet C, Goffinet F, et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999;14:1243–9
  • Strandell A, Waldenstrom U, Nillson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994;9:861–3
  • Akman MA, Garcia JE, Damewood MD, et al. Hydrosalpinx affects the implantation of previously cryopreserved embryos. Hum Reprod 1996;11:1013–14
  • Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility? Hum Reprod 2002;17:1141–5
  • Strandell A, Lindhard A, Waldenstrom U, et al. Hydrosalpinx and IVF outcome: a prospective randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999;14:2762–9
  • Déchaud H, Daurès JP, Arnal F, et al. Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization? A pilot prospective randomized study. Fertil Steril 1998;69:1020–5
  • Kontoravdis A, Makrakis E, Pantos K, et al. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril 2006;86:1642–8
  • Moshin V, Hotineanu A. Reproductive outcome of the proximal tubal occlusion prior to IVF in patients with hydrosalpinx. Hum Reprod 2006;21:i193–4
  • Vignarajan CP, Singh N. Salpingectomy versus proximal tubal occlusion for hydrosalpinges prior to in-vitro-fertilization (ivf) cycle – is there a difference in ovarian reserve or response to gonadotropins? Fertil Steril 2014;102:e136–7
  • Johnson N, van Voorst S, Sowter M, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2010;20:CD002125
  • Chanelles O, Ducarme G, Sifer C, et al. Hydrosalpinx and infertility: what about conservative surgical management? Eur J Obstet Gynecol Reprod Biol 2011;59:122–6
  • Sowter MC, Akande VA, Williams JA, Hull MG. Is the outcome of in vitro fertilization and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx? Hum Reprod 1997;12:2147–50
  • Van Voorhis BJ, Sparks AE, Syrop CH, Stovall DW. Ultrasound guided aspiration of hydrosalpinges is associated with improved pregnancy and implantation rates after in vitro fertilization cycles. Hum Reprod 1998;13:736–9
  • Hammadieh N, Coomarasamy A, Ola B, et al. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Hum Reprod 2008;23:1113–17
  • Fouda UM, Sayed AM, Abdelmoty HI, Elsetohy KA. Ultrasound guided aspiration of hydrosalpinx fluid versus salpingectomy in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET: a randomized controlled trial. BMC Women's Health 2015;15:21
  • Na ED, Cha DH, Cho JH, Kim MK. Comparison of IVF-ET outcomes in patients with hydrosalpinx pretreated with either sclerotherapy or laparoscopic salpingectomy. Clin Exp Reprod Med 2012;39:182–6
  • Jiang H, Pei H, Zhang W, Wang X. A prospective clinical study of interventional ultrasound sclerotherapy on women with hydrosalpinx before in vitro fertilization and embryo transfer. Fertil Steril 2010;94:2854–6
  • Hurst BS, Tucker KE, Awoniyi CA, Schlaff WD. Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization. Fertil Steril 2001;75:1017–19
  • Povedano B, Arjona J, Velasco E, et al. Complications of hysteroscopic Essure® sterilisation: report on 4306 procedures performed in a single centre. BJOG 2012;119:795–9
  • Arjona JE, Rodríguez B, Velasco E, et al. Essure® and chronic pelvic pain: a population-based cohort. J Obstet Gynaecol 2014;34:712–13
  • Rosenfield RB, Stones RE, Coates A, et al. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril 2005;83:1547–50
  • Galen DI. Utilization of the Essure micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization. Fertil Steril 2007;88:S16
  • Kerin JF, Cattanach S. Successful pregnancy outcome with the use of in vitro fertilization after Essure hysteroscopic sterilization. Fertil Steril 2007;87:1212. e1–4
  • Hitkari JA, Singh SS, Shapiro HM, Leyland N. Essure treatment of hydrosalpinges. Fertil Steril 2007;88:1663–6
  • Nichols JE, West JR. Success of Essure© micro-inserts in the treatment of hydrosalpinx prior to in vitro fertilization (IVF)/frozen embryo transfer (FET) and pregnancy outcomes. Fertil Steril 2010;94:S245
  • Galen DI, Khan N, Richter KS. Essure® multicenter off-label treatment for hydrosalpinx before in vitro fertilization. J Minim Invasive Gynecol 2011;18:338–42
  • Mijatovic V, Dreyer K, Emanuel MH, et al. Essure(®) hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy. Eur J Obstet Gynecol Reprod Biol 2012;161:42–5
  • Thébault N, Broux PL, Moy L, Vialard J. Utilization of Essure(®) micro-insert for hydrosalpynx occlusion in infertile women. J Gynecol Obstet Biol Reprod (Paris) 2012;41:145–50
  • Inocencio G, Coutinho L, Maciel R, Barreiro M. Pregnancy after hydrosalpinx treatment with Essure. BMJ Case Rep 2013;2013. doi: 10.1136/bcr-2013-009018
  • Matorras R, Rabanal A, Prieto B, et al. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol 2013;169:54–9
  • Legendre G, Moulin J, Vialard J, et al. Proximal occlusion of hydrosalpinges by Essure (R) before assisted reproduction techniques: a French survey. Eur J Obstet Gynecol Reprod Biol 2014;181:300–4
  • Ozgur K, Bulut H, Berkkanoglu M, et al. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients. Reprod BioMed Online 2014;29:113–18
  • Guedes-Martins L, Mesquita-Guimarães J, Barreiro M. Gravidezes bem sucedidas com recurso a fertilização in vitro após oclusão de hidrossalpinge unilateral com Essure®. Acta Med Port 2014;27:342–8
  • Velasco E, Ríos JE, Arjona JE, et al. Pregnancy outcomes and perinatal results of unintended pregnancies following Essure sterilization: descriptive study of 10 cases. Hum Reprod 2011;26:ii247
  • Veersema S, Mijatovic V, Dreyer K, et al. Outcomes of pregnancies in women with hysteroscopically placed micro-inserts in situ. J Minim Invasive Gynecol 2014;21:492–7
  • Salem SA, Peck AC, Salem RD, Sills ES. Can laparoscopic removal of Essure device before embryo transfer correct poor reproductive outcome pattern in IVF? A case report. Clin Exp Obstet Gynecol 2014;4:219–22
  • Arora P, Arora RS, Cahill D. Essure® for management of hydrosalpinx prior to in vitro fertilisation—a systematic review and pooled analysis. BJOG 2013;121:527–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.